Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myocardial Infarction: later-stage trial registry
16 of 66 indexed Myocardial Infarction trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #211 of 28,707 conditions by registered trial count.
66 US clinical trials · 16 currently recruiting · #211 of 28,707 conditions by registered trial count
Myocardial Infarction: 66 US clinical trials tracked, 16 recruiting.
Myocardial Infarction is the subject of 66 registered US clinical trials on ClinicalTrials.gov, 16 of them currently open to new participants. 14 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 5 of these trials.
Enrollment posture brief
Registry condition myocardial-infarction
OPEN 16 | RECR 24% | LATE 14 | EARLY 7 | RANK #211 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Anatomic Stage IIB Breast Cancer AJCC v8 (24% recruiting · 33 trials)
Myocardial Infarction lists 16 open slots (24% of 66 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myocardial Infarction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myocardial Infarction is recruiting below its size-band peers.
16 of 66 indexed trials (24.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Myocardial Infarction trials is spread across many organizations.
NYU Langone Health accounts for 5 of 66 trials (7.6%). 47 distinct sponsors appear on at least one study for this condition label.
-
Typical Myocardial Infarction enrolment sits around 360 participants.
Median target enrolment is 360 among the 65 trials that report a genuine target (sentinel values excluded). 12 of those (18.5%) plan for fewer than 100 participants.
-
Myocardial Infarction splits between interventional and observational designs.
38 interventional and 28 observational studies make up this index (57.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
66 total, page 2 of 2
Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)
Shockwave Medical
NCT05966662
Identify Clinical Conditions That Increase Circulating DNA Levels
University of Florida
NCT01815996
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
National Institutes of Health Clinical Center (CC)
NCT00001589
Genetic Variation in Platelet Aggregation
Vanderbilt University
NCT01576536
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI)
NCT00354328
Myocardial Ischemia and Transfusion Pilot
Rutgers, The State University of New Jersey
NCT01167582
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Genetesis
NCT03255772
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction
Mayo Clinic
NCT00587002
Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
Mesoblast
NCT00114452
Mechanisms of Action of Acetaminophen
University of Pennsylvania
NCT00646906
Exercise Prescription in Cardiac Rehabilitation
Baystate Medical Center
NCT03925493
Mindfulness & Stress Management Study for Cardiac Patients
University of Minnesota
NCT02722213
Platelet Sub-study of the TWILIGHT Trial
Juan Badimon
NCT04001374
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
University of California, San Francisco
NCT01877941
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
University of North Carolina, Chapel Hill
NCT04131816
Vitamin Therapy for Prevention of Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00004734
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
| Phase 3 | 9 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Myocardial Infarction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myocardial Infarction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myocardial Infarction page
66 registered trials, 16 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 16 Myocardial Infarction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NYU Langone Health sponsors the most Myocardial Infarction trials on record, review their full trial history before evaluating a specific study. See NYU Langone Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myocardial Infarction condition card totals 66 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.